<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>As the result of basic researches, several intravital fluorophores have been determined so far in human colorectal tissue </plain></SENT>
<SENT sid="1" pm="."><plain>Autofluorescence endoscopy (AFE) can detect slight alterations in their distribution and concentration during the colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> process and, thus facilitate noninvasive screening colonoscopies without the need for fluorescent substances or staining reagents to be administered </plain></SENT>
<SENT sid="2" pm="."><plain>While detecting faint autofluorescence intensity by conventional fiberoptic endoscopy remains challenging, the latest AFE system with high-resolution videoendoscope capabilities enables such detection by using a false-color display algorithm </plain></SENT>
<SENT sid="3" pm="."><plain>To this end, the diagnostic benefits of AFE have been reported in several multicenter randomized controlled studies of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) screening and differential diagnosis </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> screening using the latest AFE technology could, therefore, lead to future reductions in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> mortality </plain></SENT>
</text></document>